RE: RNS7 May 2026 08:35
If like me you are here for the long-term and not a quick £, its actually good from a management point of view with retention and the real drivers will still be:
sales growth,
FDA/regulatory progress,
funding position/cash runway,
partnerships,
profitability progress.
The key here is the 3.7p they expect the share price to be meaningfully higher in future, which is a positive imho. This RNS will sort the men out from the boys!